The filer, Julie Mayfield, appears to be a credible individual shareholder raising a legitimate governance and risk-management concern — not an ideological advocacy group — so the proposal merits evaluation on its merits. The ask is a disclosure report, which carries a lower bar: shareholders requesting information about how a company that explicitly names hospital acquisitions as a core strategy manages the consequences of those acquisitions is a reasonable, material ask. HCA's opposition argues it already discloses community impact broadly, but that existing disclosure consists of enterprise-wide positive highlights and does not address the specific pre-versus-post metrics (physician departures, staffing ratios, patient satisfaction changes) that would allow shareholders to assess acquisition risk management. The documented legal exposure at Mission Health — including an active North Carolina Attorney General lawsuit, five federal Immediate Jeopardy citations, and EMTALA violations — makes acquisition integration practices a genuine material risk to shareholders, not merely a social concern.

John Chevedden is a well-known individual governance activist with a long track record of filing governance-focused proposals — the policy treats his proposals as credible and takes them seriously. Written consent rights are a standard governance improvement: they give shareholders the ability to act between annual meetings without the friction of calling a formal special meeting, which at HCA requires owning 15% of shares for at least one year — a high bar that excludes many shareholders from that alternative. The company's opposition arguments about potential abuse are standard boilerplate and are not specific to HCA's situation; in practice, written consent is rarely used and the company already has other protections (no poison pill, annual elections, no supermajority requirements) that limit abuse risk. Supporting this proposal gives ordinary shareholders a stronger voice without undermining the board's ability to manage the business.